Evidence map›Paper›PMID 40559659›Full record

ArticleMarine drugs2025

Rhamnan Sulfate from the Seaweed

Takaichi Miwa, Masaya Sato, Ning Ma, Keiichi Hiramoto, Masahiro Terasawa, Koji Suzuki

Abstract read
In one paragraph

Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takaichi MiwaFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagakicho 3500-3, Suzuka 513-8670, Mie, Japan.ORCID 0009-0003-2715-3496
Masaya SatoFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagakicho 3500-3, Suzuka 513-8670, Mie, Japan.ORCID 0009-0002-2569-4152
Ning MaGraduate School of Health Science, Suzuka University of Medical Science, Kishioka-cho 1275-3, Suzuka 510-0226, Mie, Japan.ORCID 0000-0001-7315-8835
Keiichi HiramotoFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagakicho 3500-3, Suzuka 513-8670, Mie, Japan.
Masahiro TerasawaKonan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Mie, Japan.ORCID 0000-0003-1250-1569
Koji SuzukiFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagakicho 3500-3, Suzuka 513-8670, Mie, Japan.

Funding

the Japan Society for the Promotion of Science 19K08850
6 · The paper itself

Abstract

Rhamnan sulfate (RS), extracted from the seaweed

Indexed as

Cognitive DysfunctionHyperglycemiaRhodophytaSeaweedAnimalsBlood GlucoseBrainChlorophytaDiabetes Mellitus, ExperimentalDisease Models, AnimalEdible SeaweedsMaleMiceStreptozocinTumor Necrosis Factor-alphaBlood GlucoseStreptozocinTumor Necrosis Factor-alphadiabetic cognitive impairmenthippocampal atrophymicrogliaMonostroma nitidumrhamnan sulfate

Identifiers

PMID40559659
PMCPMC12193936

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.